CDOClass I

Acid, Uric, Uricase (U.V.)

21 CFR 862.1775 / Clinical Chemistry

CDO is the FDA product code for Acid, Uric, Uricase (U.V.), a class I device type, regulated under 21 CFR 862.1775. As of 2026-09-10, FDA records hold 31 510(k) clearances under this code, the most recent dated 2004-02-27, and one recall.

Classification record

Product code: CDO
Device name: Acid, Uric, Uricase (U.V.)
Regulation: 21 CFR 862.1775
Device class: Class I
Review panel: Clinical Chemistry
Submission type: 510(k) exempt
Implant: No
Life sustaining or supporting: No
GMP exempt: No
Third party review eligible: No
Ingested clearances: 31
Ingested recalls: 1

Clearances, product code CDO

By decision year

31 clearances under product code CDO with a decision year between 1976 and 2004, 1982 the highest year at 5.

Show the numbers

510(k) clearances under FDA product code CDO by decision year
Year	Clearances
1976	1
1977	3
1978	1
1979	2
1980	3
1981	2
1982	5
1985	1
1986	1
1987	1
1988	1
1990	1
1992	1
1993	1
1996	1
1997	1
1998	3
1999	1
2004	1

Applicants with the most clearances

Product code CDO

Applicants holding the most 510(k) clearances under product code CDO
Applicant	Clearances
Em Diagnostic Systems, Inc.	4
Abbott Medical	2
EMD Millipore Corporation	2
Sigma Diagnostics, Inc.	2
Worthington Biochemical Corp.	2
BD Becton Dickinson Vacutainer Systems Preanalytic	1
Biorent Diagnostic, Inc.	1
Biotrol, USA, Inc.	1
Boehringer Mannheim Corp.	1
Calbiochem-Behring Corp.	1

Companies listing this code with FDA

Companies whose registered establishments list this code